BRPI1009752A2 - Sistema de vetor de expressão comprendendo dois marcadores de seleção - Google Patents

Sistema de vetor de expressão comprendendo dois marcadores de seleção

Info

Publication number
BRPI1009752A2
BRPI1009752A2 BRPI1009752-0A BRPI1009752A BRPI1009752A2 BR PI1009752 A2 BRPI1009752 A2 BR PI1009752A2 BR PI1009752 A BRPI1009752 A BR PI1009752A BR PI1009752 A2 BRPI1009752 A2 BR PI1009752A2
Authority
BR
Brazil
Prior art keywords
expression vector
vector system
selection markers
markers
selection
Prior art date
Application number
BRPI1009752-0A
Other languages
English (en)
Inventor
Thomas Jostock
Hans-Peter Knopf
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI1009752A2 publication Critical patent/BRPI1009752A2/pt
Publication of BRPI1009752B1 publication Critical patent/BRPI1009752B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C12N9/003Dihydrofolate reductase [DHFR] (1.5.1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y105/00Oxidoreductases acting on the CH-NH group of donors (1.5)
    • C12Y105/01Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
    • C12Y105/01003Dihydrofolate reductase (1.5.1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/40Systems of functionally co-operating vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI1009752-0A 2009-02-27 2010-02-26 Vetor de expressão ou uma combinação de pelo menos dois vetores de expressão e métodos para sua produção e sua seleção, bem como processo para produzir um produto de interesse e uso de um meio de cultura seletivo BRPI1009752B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09153995 2009-02-27
EP09153995.7 2009-02-27
PCT/EP2010/001224 WO2010097240A1 (en) 2009-02-27 2010-02-26 Expression vector system comprising two selection markers

Publications (2)

Publication Number Publication Date
BRPI1009752A2 true BRPI1009752A2 (pt) 2015-08-25
BRPI1009752B1 BRPI1009752B1 (pt) 2020-03-10

Family

ID=40886421

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009752-0A BRPI1009752B1 (pt) 2009-02-27 2010-02-26 Vetor de expressão ou uma combinação de pelo menos dois vetores de expressão e métodos para sua produção e sua seleção, bem como processo para produzir um produto de interesse e uso de um meio de cultura seletivo

Country Status (16)

Country Link
US (3) US9534226B2 (pt)
EP (1) EP2401377B1 (pt)
JP (2) JP5801207B2 (pt)
KR (1) KR101707251B1 (pt)
CN (1) CN102333871B (pt)
BR (1) BRPI1009752B1 (pt)
CA (1) CA2753814C (pt)
DK (1) DK2401377T3 (pt)
ES (1) ES2587630T3 (pt)
IL (1) IL214621A (pt)
MX (1) MX2011009025A (pt)
PL (1) PL2401377T3 (pt)
PT (1) PT2401377T (pt)
RU (2) RU2535986C2 (pt)
SG (1) SG173456A1 (pt)
WO (1) WO2010097240A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5801207B2 (ja) 2009-02-27 2015-10-28 ノバルティス アーゲー 2種類の選択マーカーを含む発現ベクター系
CN103201382A (zh) * 2010-11-08 2013-07-10 日本化学研究株式会社 新表达载体
MX359950B (es) 2012-11-20 2018-10-17 Novartis Ag Casete de expresión optimizado para expresar un polipéptido con un alto rendimiento.
WO2014141037A1 (en) 2013-03-11 2014-09-18 Novartis Ag Method of screening cell clones
RU2716977C2 (ru) * 2013-07-31 2020-03-17 Новартис Аг Новые селективные векторы и способы селекции эукариотических клеток-хозяев
JP6708548B2 (ja) 2013-12-20 2020-06-10 ノバルティス アーゲー 新規真核細胞および目的の生成物を組換え発現させるための方法
EP3083677B1 (en) 2013-12-20 2019-08-28 Novartis AG Novel eukaryotic cells and methods for recombinantly expressing a product of interest
PL3137595T3 (pl) 2014-04-29 2019-09-30 Novartis Ag Nowe komórki kręgowców i sposoby ekspresji rekombinowanej polipeptydu będącego przedmiotem zainteresowania
US20180066268A1 (en) * 2015-04-03 2018-03-08 Selexis S.A. Use of vitamins and vitamin metabolic genes and proteins for recombinant protein production in mammalian cells
UY37758A (es) * 2017-06-12 2019-01-31 Novartis Ag Método de fabricación de anticuerpos biespecíficos, anticuerpos biespecíficos y uso terapéutico de dichos anticuerpos
US20200370056A1 (en) 2017-10-02 2020-11-26 Astrazeneca Ab Cell lines and methods for increased protein production
KR102729768B1 (ko) * 2017-10-12 2024-11-14 더 잭슨 래보라토리 트랜스제닉 선택 방법 및 조성물
CN114401769A (zh) * 2019-03-27 2022-04-26 菲尼克斯组织修复公司 生产胶原蛋白7组合物的系统和方法
EP4247947A1 (en) * 2020-11-19 2023-09-27 Genzyme Corporation Flow cytometry attenuated reporter expression (flare) multiple reporter system and methods of use thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0724639B1 (en) 1991-03-29 2001-01-31 Genentech, Inc. Methods for selection of recombinant host cells expressing high levels of a desired protein
US5439808A (en) 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5830698A (en) * 1997-03-14 1998-11-03 Idec Pharmaceuticals Corporation Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
DE10036491A1 (de) * 2000-07-25 2002-02-07 Roche Diagnostics Gmbh Expression von Alkalischer Phosphatase in Hefe
US7384744B2 (en) * 2002-11-29 2008-06-10 Boehringer Ingelheim Pharma Gmbh & Co., Kg Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
DE10256083A1 (de) * 2002-11-29 2004-08-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen
US7824907B2 (en) 2003-03-11 2010-11-02 Merck Serono Sa Expression vectors comprising the mCMV IE2 promoter
TW200513351A (en) * 2003-07-17 2005-04-16 Availvs Corp High pressure water jet surface cutting device and cutting method
DK1716233T3 (da) * 2004-01-30 2009-10-26 Maxygen Holdings Ltd Reguleret stopkodongennemlæsning
WO2007096399A2 (en) 2006-02-21 2007-08-30 Chromagenics B.V. Selection of host cells expressing protein at high levels
IL165484A0 (en) * 2004-11-30 2006-01-15 Applied Research Systems Production of proteins
EP2027273B1 (en) 2006-05-17 2016-04-13 F. Hoffmann-La Roche AG Polypeptide producing cells
BRPI0821401A2 (pt) 2007-12-21 2014-10-14 Novartis Ag Compostos orgânicos
AU2009286956B2 (en) 2008-08-28 2012-12-06 Novartis Ag Cell surface display of polypeptide isoforms by stop codon readthrough
JP5801207B2 (ja) 2009-02-27 2015-10-28 ノバルティス アーゲー 2種類の選択マーカーを含む発現ベクター系
US8962274B2 (en) 2009-02-27 2015-02-24 Novartis Ag Methods for selecting eukaryotic cells expressing a heterologous protein
RU2716977C2 (ru) 2013-07-31 2020-03-17 Новартис Аг Новые селективные векторы и способы селекции эукариотических клеток-хозяев

Also Published As

Publication number Publication date
RU2011139182A (ru) 2013-04-10
KR101707251B1 (ko) 2017-02-15
PL2401377T3 (pl) 2016-11-30
ES2587630T3 (es) 2016-10-25
RU2014101759A (ru) 2015-08-10
US20180265891A1 (en) 2018-09-20
US20170067077A1 (en) 2017-03-09
JP5801207B2 (ja) 2015-10-28
MX2011009025A (es) 2011-09-28
US9994866B2 (en) 2018-06-12
EP2401377A1 (en) 2012-01-04
EP2401377B1 (en) 2016-05-18
CN102333871B (zh) 2013-12-04
JP2012518992A (ja) 2012-08-23
RU2535986C2 (ru) 2014-12-20
US11174494B2 (en) 2021-11-16
CN102333871A (zh) 2012-01-25
AU2010219089A1 (en) 2011-08-18
PT2401377T (pt) 2016-08-18
IL214621A0 (en) 2011-09-27
IL214621A (en) 2016-02-29
JP2015109839A (ja) 2015-06-18
CA2753814A1 (en) 2010-09-02
RU2649361C2 (ru) 2018-04-02
BRPI1009752B1 (pt) 2020-03-10
US20110306092A1 (en) 2011-12-15
DK2401377T3 (en) 2016-08-29
KR20110119837A (ko) 2011-11-02
WO2010097240A1 (en) 2010-09-02
US9534226B2 (en) 2017-01-03
SG173456A1 (en) 2011-09-29
CA2753814C (en) 2018-07-31

Similar Documents

Publication Publication Date Title
BRPI1009752A2 (pt) Sistema de vetor de expressão comprendendo dois marcadores de seleção
BRPI1014643A2 (pt) sistema de antenas distribuídas
BRPI1010217A2 (pt) sistema
EP2307902A4 (en) WIRELESS LOCATION SYSTEM
BRPI1010873A2 (pt) vetor genético
ES2864688T8 (es) Sistema de ablación
BR112013011964A2 (pt) sistema de navegação
BR112013007839A2 (pt) sistema de refrigeração
BRPI1012833A2 (pt) sistema de conexão de comunicação
BRPI1007799A2 (pt) sistema anti-erosão
BRPI0912054A2 (pt) sistema de posicionamento
BRPI0822520A2 (pt) Sistema de plasma
BR112013001593A2 (pt) ''sistema de distribuição''
BR112013021322A2 (pt) sistema de transferência de fluido
BR112013011835A2 (pt) sistema de compensação de deslocamento
BR112013011955A2 (pt) sistema de distribuição de anúncio
DK2482768T3 (da) Intrauterint system
BRPI1006691A2 (pt) sistema
IT1400794B1 (it) Sistema di iniezione
BRPI1014417A2 (pt) sistema
BR112012026166A2 (pt) sistema de cobertura
BRPI0922999A2 (pt) sistema submarino
BR112012003347A2 (pt) sistema
BRPI1006688A2 (pt) sistema
BR112012003179A2 (pt) sistema bio-eletrônico

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2020, OBSERVADAS AS CONDICOES LEGAIS.